Sign in

CIK 0001704292 · Large accelerated filer

Zai Lab Ltd

Sign in to watch
Ticker
ZLAB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Cayman Islands
Entity type
operating
Phone
862161632588
Business address
899 HALEI ROAD, BUILDING B, PUDONG, SHANGHAI, China
Former names
Zai Lab Ltd
  1. 4 Planned sale See Remarks sold 3,000 shares at $35.00 ($105,000)
  2. 4 Planned sale Chief Financial Officer sold 4,096 shares at $34.01 ($139,305)
  3. 4 Planned sale Chairperson & CEO sold 100,000 shares at an average $34.69 ($3,468,970)
  4. 4 Derivatives Options or other derivatives
  5. 4 Open-market sale Chairperson & CEO sold 7,072 shares at $35.23 ($249,147)
  6. 4 Open-market sale Chairperson & CEO sold 6,918 shares at $35.52 ($245,727)
  7. 4 Open-market sale Chief Legal Officer sold 5,877 shares at $36.13 ($212,348)
  8. 4 Open-market sale Chairperson & CEO sold 23,669 shares at $36.13 ($855,208)
  9. 4 Open-market sale Chief Financial Officer sold 2,675 shares at $36.13 ($96,653)
  10. 4 Grant or award Director acquired 10,831 shares (grant or award)
  11. 4 Grant or award Director acquired 10,831 shares (grant or award)
  12. 4 Grant or award Director acquired 10,831 shares (grant or award)
  13. 4 Grant or award Director acquired 10,831 shares (grant or award)
  14. 4 Grant or award Director acquired 10,831 shares (grant or award)
  15. 4 Grant or award Director acquired 10,831 shares (grant or award)
  16. 4 Planned sale Director sold 13,814 shares at $35.67 ($492,745)
  17. 4 Grant or award Director acquired 10,831 shares (grant or award)
  18. 4 Planned sale Chief Financial Officer sold 9,618 shares at $30.00 ($288,540)
  19. 4 Planned sale Chairperson & CEO sold 96,389 shares at an average $28.34 ($2,731,507)
  20. 4 Open-market sale Director sold 23,799 shares at $30.05 ($715,086)

Page 4 of 15 · 288 filings